R2 Technology to sell ImageChecker in Japan
Mammography computer-aided detection firm R2 Technology’s ImageChecker CAD unit has received approval from the Japanese Ministry of Health and Welfare for use in breast cancer screening in Japan. The unit will be distributed by R2’s partner,
Mammography computer-aided detection firm R2 Technologys ImageChecker CAD unit has received approval from the Japanese Ministry of Health and Welfare for use in breast cancer screening in Japan. The unit will be distributed by R2s partner, Marubeni America, with which R2 signed an agreement last spring (SCAN 6/23/99).
The MHWs decision came as more good news for the Los Altos, CA, company, which is seeing its efforts to establish industry alliances pay off. In 1998, R2 signed an exclusive OEM supply deal with GE Medical Systems of Milwaukee. GE agreed to bundle ImageChecker with the full-field digital mammography system it had under development (SCAN 4/29/98). With the Food and Drug Administrations Jan. 31 approval of GEs Senographe (see story, page 5), R2 comes closer to bringing a digital version of ImageChecker to market.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
